Novartis has posted a healthy rise in sales and profits in the first full quarter since it separated from Sandoz and proposed former Bristol Myers Squibb’s chief executive Giovanni Caforio as its ...
This guidance updates and replaces NICE's highly specialised technologies guidance 12 on cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2, which was available with managed access.
Get a great machine for cheap with our top-rated picks for budget laptops all costing $1,000 or less.